Small Cell Lung Cancer is the Most Likely Diagnosis
The most likely cause of this patient's symptoms is small cell lung cancer (SCLC). This presentation represents a classic paraneoplastic syndrome—specifically, syndrome of inappropriate antidiuretic hormone secretion (SIADH)—which is strongly associated with SCLC and explains the entire clinical picture.
Clinical Reasoning
Why Small Cell Lung Cancer?
This 66-year-old man presents with a constellation of findings that point directly to SCLC:
- Hilar mass on imaging - A central/hilar location is characteristic of SCLC, which typically arises from central bronchi
- Severe hyponatremia (Na 127 mmol/L) - SIADH occurs in 10-15% of SCLC patients, making it the most common malignancy associated with this paraneoplastic syndrome
- Confusion - Direct result of hyponatremia affecting neurological function
- Shortness of breath - Can be explained by the tumor mass itself, not necessarily PE
The DVT Connection
The initial DVT three weeks ago is highly significant. Unprovoked DVT in a patient of this age should immediately raise suspicion for occult malignancy. Cancer-associated thrombosis (Trousseau syndrome) is well-documented, and SCLC is particularly thrombogenic. The DVT was likely the first clinical manifestation of his underlying malignancy.
According to current guidelines, patients with unprovoked VTE should receive extended anticoagulation when persistent risk factors like cancer are present 1. However, the key issue here is that the DVT was a red flag for malignancy that warranted further investigation.
Why Not the Other Options?
Pulmonary Embolism (Option B)
While PE remains on the differential—especially given his recent DVT and dyspnea—several factors argue against it as the primary diagnosis:
- PE does not explain the hilar mass
- PE does not cause hyponatremia
- He is already on therapeutic anticoagulation for 3 weeks 1
- The confusion is better explained by hyponatremia than by PE alone
That said, PE could coexist with the cancer diagnosis and should still be evaluated with appropriate imaging if clinically indicated.
Sarcoidosis (Option C)
Sarcoidosis can present with hilar masses (bilateral hilar lymphadenopathy), but:
- It rarely causes significant hyponatremia
- The acute presentation with confusion is atypical
- The age and clinical context (recent DVT) make malignancy far more likely
- Sarcoidosis doesn't explain the hypercoagulable state leading to DVT
Adenocarcinoma (Option D)
While adenocarcinoma is the most common lung cancer overall:
- It typically presents as peripheral masses, not hilar
- SIADH is much less common with adenocarcinoma compared to SCLC
- The central location strongly favors SCLC
Critical Next Steps
Immediate management priorities:
Correct the hyponatremia cautiously - Fluid restriction initially; consider hypertonic saline if severely symptomatic, but correct slowly (≤8-10 mEq/L per 24 hours) to avoid osmotic demyelination syndrome
Obtain tissue diagnosis - Bronchoscopy with biopsy of the hilar mass for definitive diagnosis
Continue anticoagulation - Per guidelines, patients with cancer-associated VTE require extended anticoagulation 1. Consider LMWH over oral anticoagulants in active malignancy, though newer evidence supports DOACs in selected cancer patients 2
Stage the cancer - CT chest/abdomen/pelvis and brain MRI if SCLC confirmed
Common Pitfalls to Avoid
- Don't dismiss unprovoked DVT in older adults - Always consider occult malignancy and pursue appropriate cancer screening
- Don't attribute all symptoms to PE - The hilar mass and hyponatremia demand explanation beyond thromboembolism
- Don't correct hyponatremia too rapidly - Risk of central pontine myelinolysis is real and devastating
- Don't delay tissue diagnosis - The patient needs definitive pathology to guide cancer-specific therapy
The combination of unprovoked DVT, central hilar mass, and severe hyponatremia with confusion creates a clinical picture that overwhelmingly points to small cell lung cancer with paraneoplastic SIADH.